What You Should Know:
- Ontada, a McKesson business specializing in real-world data and clinical technology for community oncology, has announced a strategic collaboration with Datavant, a health data platform.
- The partnership aims to accelerate oncology innovation by providing life science companies with faster access to Ontada's comprehensive real-world data.
In October, Ontada partnered with Microsoft to utilize AI capabilities to extract actionable insights from vast
Read More
real-world data (RWD)
Flatiron Health and Lifebit Partner to Enhance Cancer Care in Japan through Real-World Data
What You Should Know:
- Flatiron Health, and Lifebit Biotech Ltd (UK, London; hereafter “Lifebit”), are expanding their collaboration into Japan to transform cancer care, facilitating ground breaking research by allowing for safe and secure access to real-world data (RWD).
- Building on the success of their multi-year strategic partnership, Lifebit’s pioneering federated Trusted Research Environment (TRE) technology will enable safe and secure access to Flatiron Health’s high-quality
Read More
Panalgo Partners with COTA to Enhance AI & RWD-Enabled Cancer Care
What You Should Know:
- Panalgo, a provider of healthcare data analytics solutions, has announced a partnership with COTA, an organization focused on providing real-world data (RWD) for cancer care.
- The strategic collaboration will enable COTA to make its high-quality hematologic oncology data available through Panalgo's Instant Health Data Analytics (IHD) platform.
Leveraging COTA's Real-World Data
COTA's RWD is derived from electronic health records (EHRs) and offers
Read More
COTA and FDA Extend Collaboration to Advance Use of Real-World Data in Cancer Research
What You Should Know:
- COTA, a leader in real-world data and analytics solutions, today announced a five-year extension of its research collaboration with the U.S. Food and Drug Administration's (FDA) Oncology Center of Excellence (OCE).
- The five-year extension builds upon a successful partnership established in 2018 and signifies a continued commitment to utilizing real-world data (RWD) to enhance cancer treatment and regulatory decisions.
Building on a Successful
Read More
COTA & Sanofi Partner to Leverage Real-World Data and AI to Accelerate Cancer Trials
What You Should Know:
- COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi.
- The strategic partnership aims to leverage RWD and artificial intelligence (AI) to accelerate clinical trials specifically focused on multiple myeloma, a cancer affecting white blood cells. The findings from this partnership have the potential to significantly impact future clinical trial designs for multiple myeloma.
Unlocking
Read More
Flatiron Health, NCCN Collaborate to Advance Cancer Care with Real-World Data
What You Should Know:
- Flatiron Health, a provider of real-world data (RWD) for cancer care, and the National Comprehensive Cancer Network® (NCCN®), an alliance of top cancer centers, have announced a renewal of their long-standing collaboration.
- This decade-long partnership, dating back to 2014, focuses on leveraging RWD to improve cancer care and research.
The Power of Real-World Data in Cancer Care
Real-world data offers a valuable window into the realities of
Read More
Verantos Bolsters Real-World Data Network with 7M Patient Records from CuriMeta
What You Should Know:
- Verantos, the leader in high-quality real-world evidence (RWE) forms a strategic partnership with CuriMeta to expand Verantos' Research Network with de-identified data from 7 million patients,
- The collaboration will enhance the depth and reach of real-world data (RWD) available to life science organizations.
Enhancing RWD Quality and Accessibility
The Verantos Research Network is a unique platform that gathers data from various sources, including academic
Read More
Tempus Donates Over 3,000 Cancer Patient Profiles to Fuel National Cancer Institute Research
What You Should Know:
- Tempus, a leader in artificial intelligence and precision medicine, announced a groundbreaking data contribution to the National Cancer Institute (NCI) today.
- The first-of-its-kind contribution will significantly enhance the NCI's planned Data Enclave, a secure repository designed to accelerate cancer research.
Unlocking Insights from 3,000 Cancer Diagnoses
Tempus is donating de-identified tumor profiles with limited associated clinical information from over
Read More
MUSC Hollings Cancer Center and Flatiron Health Partner to Deliver Advanced Cancer Care
What You Should Know:
- The Medical University of South Carolina (MUSC) Hollings Cancer Center and Flatiron Health, a leading oncology-focused healthtech company, today announced a collaboration to bring Flatiron Assist™ to MUSC's oncology care clinicians.
- The strategic collaboration equips clinicians at MUSC Hollings Cancer Center with Flatiron Assist, a unique clinical decision support platform designed specifically for oncology. Flatiron Assist prioritizes the latest
Read More
Trilliant Health Launches Network Explorer: An Application To Improve Network Performance With Real-World Data
What You Should Know:
Trilliant Health, the leading provider of data-driven strategy analytics for the health economy, announced the launch of Network Explorer, a point-and-click application to manage network performance.Network Explorer enables stakeholders across the health economy to form evidence-based strategies to improve their network performance. Limited to their own data, no health economy stakeholder has a full picture of the scope of physician-patient interactions, leaving
Read More
